Oncology News

ESMO oncology news ensures that you're always kept up to date with the latest developments that affect you and your daily practice. Make sure you check these pages frequently, or sign up to our newsletter.

Filter

Date Title Topic
03 Jan 2018 FDA Grants Regular Approval to Nivolumab for Adjuvant Treatment of Melanoma Melanoma and other skin tumours - Cancer Immunology and Immunotherapy
02 Jan 2018 FDA Grants Accelerated Approval to Bosutinib Haematologic malignancies - Anticancer agents & Biologic therapy
02 Jan 2018 FDA Grants Regular Approval to Adjuvant Pertuzumab for HER2-positive Early Breast Cancer Breast cancer - Anticancer agents & Biologic therapy
22 Dec 2017 FDA Grants Regular Approval to Cabozantinib Genitourinary cancers - Anticancer agents & Biologic therapy
21 Dec 2017 Clinical and Molecular Characterisation of CUP Carcinoma of unknown primary site - Personalised medicine
20 Dec 2017 The Antibody–Drug Conjugate Target Landscape Anticancer agents & Biologic therapy
19 Dec 2017 EMA Recommends Approval of Herzuma for the Treatment of Breast and Gastric Cancer Breast cancer - Gastrointestinal cancers - Anticancer agents & Biologic therapy
18 Dec 2017 EMA Recommends Extension of Therapeutic Indications for Ipilimumab Melanoma and other skin tumours - Cancer in Special Situations - Cancer Immunology and Immunotherapy
15 Dec 2017 NICE Issues Technology Appraisal Guidance on Atezolizumab in Advanced Urothelial Cancer Genitourinary cancers - Cancer Immunology and Immunotherapy
12 Dec 2017 Brentuximab Vedotin with Chemotherapy in Frontline Treatment of Advanced Hodgkin’s Lymphoma Haematologic malignancies - Anticancer agents & Biologic therapy
13 Dec 2017 First-line Ribociclib Improves PFS in Pre- and Peri-menopausal Women with HR-positive, HER2-negative Advanced Breast Cancer Breast cancer - Anticancer agents & Biologic therapy
11 Dec 2017 MMR Deficiency Screening is Under-utilised in Young Adult Patients with Colorectal Cancer Gastrointestinal cancers - Cancer in Special Situations
06 Dec 2017 FDA Approves Ogivri as a Biosimilar to Herceptin Breast cancer - Anticancer agents & Biologic therapy
05 Dec 2017 EMA Issues Warning About Use of Radium-223 Dichloride in Combination With Abiraterone Acetate and Prednisone or Prednisolone Genitourinary cancers - Anticancer agents & Biologic therapy
04 Dec 2017 FDA Grants Marketing Approval to FoundationOne CDx In Vitro Diagnostic Personalised medicine